From the European Hematology Association 2010 Congress: For Patients with Follicular Lymphoma, Rituximab Maintenance Therapy Cuts Risk of Recurrence in Half (Phase III PRIMA Study)
- Author
- Oncology Times
- Published
- Thu 17 Jun 2010
- Episode Link
- https://traffic.libsyn.com/secure/otbroadcastsarchives/GillesSallesPodcastOTBN.mp3
